Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.6915
-0.0335 (-4.62%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $30.08 million as of September 1, 2026. Its market cap has decreased by -22.71% in one year.
Market Cap
30.08M
Enterprise Value
29.93M
1-Year Change
-22.71%
Ranking
Category
Stock Price
$0.69
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $30.08M, an increase of 1,592.10%. That is a compound annual growth rate of 107.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 30.08M | -48.94% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 34.04M |
| Lite Strategy | 33.36M |
| BriaCell Therapeutics | 32.50M |
| Kyntra Bio | 32.47M |
| IGC Pharma | 32.05M |
| Actinium Pharmaceuticals | 31.76M |
| Barinthus Biotherapeutics | 30.49M |
| NanoViricides | 28.25M |